Classifications

• • C—CHEMISTRY; METALLURGY
  • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
  • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
  • C02F1/00—Treatment of water, waste water, or sewage
  • C02F1/50—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
  • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
  • A01N25/10—Macromolecular compounds
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
  • A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
  • A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
  • A01N47/44—Guanidine; Derivatives thereof
• • C—CHEMISTRY; METALLURGY
  • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
  • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
  • C02F1/00—Treatment of water, waste water, or sewage
  • C02F1/001—Processes for the treatment of water whereby the filtration technique is of importance
  • C02F1/002—Processes for the treatment of water whereby the filtration technique is of importance using small portable filters for producing potable water, e.g. personal travel or emergency equipment, survival kits, combat gear
• • C—CHEMISTRY; METALLURGY
  • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
  • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
  • C02F2303/00—Specific treatment goals
  • C02F2303/04—Disinfection

Definitions

• This disclosure is generally in the field of antimicrobial polymeric materials and devices useful in the purification of fluids.
• Cysts such as those represented by Giardia minis or Giardia lamblia, are widespread, disease-inducing, and resistant to most forms of chemical disinfection.
• a device claiming cyst-removal must show a minimum 3 -log reduction (99.9% of cysts removed) from an influent concentration of lxl0 6 per L or 1x10 7 per L.
• Various water soluble antimicrobial chemical agents are known in the art.
• Such conventional materials include soaps/detergents, surfactants, acids, alkalis, heavy metals, halogens, alcohols, phenols, oxidizing agents and alkylating agents. Most of these agents chemically alter (e.g., by an oxidation reaction, etc.) the cellular structure of microbes to inactivate them. Strong oxidants, such as phenols and hypochlorites, may effectively negate the potential threat of all microorganisms in water; however, unacceptable residual levels of these agents and/or their byproducts remain in the treated water and generally must be removed before the treated water can be consumed or used in other applications.
• Chlorhexidine is a 1,6-di (4-chlorophenyl-diguanido) hexane having the chemical formula:
• chlorhexidine has a high level of antibacterial activity and low mammalian toxicity. Historically, chlorhexidine has been used in fluid treatment only in its soluble salt forms. Chlorhexidine salts, however, have an extremely bitter taste that must be masked in formulations intended for oral use. The rate of reaction for the soluble chlorhexidine salts or its conventional derivatives is second-order, as the reaction depends on both the concentration of chlorhexidine and the active sites of microorganisms. It would be desirable to provide an antimicrobial material which functioned effectively as a zero order reaction.
• UV radiation ultraviolet
• the antimicrobial material would be desirable for the antimicrobial material to work effectively as an antimicrobial material without being water soluble, so as not to detrimentally impact the quality of the aqueous fluid to be filtered and in order to avoid having to remove the residual antimicrobial material or by products from the treated fluid. It would be further desirable for the material to be readily adaptable for use in various conventional flow- through fluid filtration/purification systems, without the need for an additional power source. Desirably, the purification material would significantly exceed the minimum EPA requirements for designation as a microbial water purifier such that it is suitable for consumer and industry point-of-use applications.
• the antimicrobial polymeric material may comprise a composition comprising a miscible blend of at least one antimicrobial bisguanide compound blended with at least one thermoplastic polymer.
• the miscible blend may comprise from about 1% to about 25% by weight of the at least one antimicrobial bisguanide compound.
• the antimicrobial bisguanide compound comprises chlorhexidine and the at least one thermoplastic polymer comprises a polyolefin.
• the method comprises: melting an antimicrobial bisguanide compound and a thermoplastic polymer with which the antimicrobial bisquanide compound is miscible; mixing the melted antimicrobial bisguanide compound and the melted thermoplastic polymer to form a miscible blend of the antimicrobial bisguanide compound dispersed in the thermoplastic polymer, and cooling the miscible blend to solidify the blend.
• the method further comprises processing the solidified blend into a particulate form.
• the miscible blend is extruded into fibers before solidifying the miscible blend.
• the device comprises a housing having at least one inlet orifice and at least one outlet orifice and an antimicrobial material secured within the housing and configured to contact a fluid flowing through the housing between the inlet orifice and the outlet orifice.
• the antimicrobial material desirably comprises a miscible blend of an antimicrobial bisguanide compound blended with at least one thermoplastic polymer, wherein the miscible blend is from about 1% to about 25% by weight antimicrobial bisguanide compound.
• the antimicrobial bisquanide compound comprises chlorhexidine and the at least one thermoplastic polymer comprises a polyolefin.
• the miscible blend is in the form of loose particles.
• the miscible blend is in the form of a porous monolithic structure, such as a sintered disk or block.
• the miscible blend is in the form of a nonwoven material.
• Also provided is a method for inactivating microbiological contaminants in a fluid comprising contacting the fluid with a miscible blend of an antimicrobial bisguanide compound and at least one thermoplastic polymer, wherein the miscible blend is from about 1% to about 25% by weight antimicrobial bisguanide compound.
• the fluid desirably flows through pores in or among an aggregation of particles comprising the miscible blend.
• Figures 1 A and 1 B are SEM images of a chlorhexidine-polyethylene composition.
• Figure 2 is a cross-sectional view illustrating one embodiment of a fluid treatment device comprising an antimicrobial polymeric material.
• Figures 3 A and 3B are schematic views of one embodiment of an antimicrobial polymeric material in the form of a sheet or film.
• Figures 4A and 4B are illustrations of a method for preparing an antimicrobial polymeric material according to some embodiments.
• Figure 5 is an illustration of an extrusion process for preparing an antimicrobial polymeric material according to an embodiment.
• Figures 6A and 6B are TGA thermograms of chlorhexidine and chlorhexidine hydrate.
• Figures 7A and 7B are DSC thermograms of chlorhexidine and chlorhexidine hydrate.
• Figures 8 A and 8B are SEM images of a mixture of chlorhexidine and resin.
• Figures 9A and 9B are SEM images of E. coli cells exposed to an antimicrobial polymer material according to an embodiment.
• Figure 10 is an SEM image of E. coli cells exposed to conventional antimicrobial materials.
• Solid solutions of antimicrobial bisguanide compounds blended with certain thermoplastic polymers have been developed to obtain antimicrobial polymeric materials. They may be processed into particulate form for use as or in fluid treatment devices and processes.
• the alloy material advantageously may be easily processed into a variety of physical forms for use in fluid treatment.
• the antimicrobial bisguanide compound such as chlorhexidine
• the antimicrobial bisguanide compound is distributed at the molecular level within at least one thermoplastic polymer, such as a poly olefin in which the antimicrobial bisguanide compound is soluble.
• these components are melted and blended together to form a miscible blend, sometimes herein called a polymer alloy.
• the blend is cooled to solidify the blend and then the blend is processed into a particulate form.
• the blend particles can be provided in a porous disk form or otherwise incorporated into a particle bed for contacting a fluid flowing therethrough. Passage of a fluid in need of antimicrobial treatment through pores in and among the polymer alloy particles inactivates microorganisms in the fluid. In another embodiment, the blend is extruded into fibers for forming nonwoven and woven materials.
• the alloy material provides an improvement over the conventional soluble bisguanide salts (e.g., chlorhexidine gluconate, etc.), over conventional crystalline bisguanide base forms (e.g., chlorhexidine, etc.), and over bisguanide hydrates, which are described in U.S. Patent No. 7,427,409.
• the alloy material also provides an improvement over prior art combinations of polymers with soluble bisguanide salts, crystalline bisguanide base forms, and bisguanide hydrates by providing an antimicrobial agent in a form which is immobilized with a polymer and which is water-insoluble.
• the alloy materials provided herein overcome problems associated with the thermal degradation of the antimicrobial bisguanide compound during processing, thereby retaining the material's antimicrobial activity.
• the antimicrobial bisguanide compound remains immobilized within the thermoplastic polymer, thereby avoiding problems associated with leaching of the antimicrobial bisguanide compound from the alloy material.
• the antimicrobial bisguanide compounds lose their natural morphology upon preparation of the antimicrobial polymeric material. For example, a scanning electron micrograph ( Figures IA and IB) of the cross-section of one embodiment of the antimicrobial polymeric material, a chlorhexidine-polyethylene composition, shows no evidence of the crystalline form of the bisguanide.
• the loss of the typical orthorhombic structure of the antimicrobial bisguanide (e.g., chlorhexidine) within the polymer material is due to its chemical and physical compatibility with certain thermoplastic polymers. This compatibility allows for the molecular dispersion of the bisguanide molecules with the polymer molecules, thereby preventing the bisguanide molecules from reforming their natural lattice structures.
• the antimicrobial bisguanide e.g., chlorhexidine
• the present antimicrobial polymeric materials, devices, and methods operate by physical/mechanical contact between the blend material and the fluid to be treated.
• Microorganisms in the fluid can be inactivated by contact (e.g., transient contact) with the blend material.
• Inactivation of the microorganisms is a physical phenomenon and need not (but optionally could) further include removal of the skeletal remains of the inactivated microorganisms from the fluid, e.g., by filtration.
• antimicrobial polymeric material refers to a blend that comprises at least one antimicrobial bisguanide compound in a solid solution with at least one thermoplastic polymer, wherein the resulting material exhibits antimicrobial activity.
• the antimicrobial polymeric material also may be referred to herein as a "purification material.”
• the antimicrobial polymeric material may be in essentially any structure or form that provides sufficient contact with the fluid to be treated.
• the structure may be in a loose granular or particulate form, or the structure may be in a unitary form in various geometric configurations, such as sheets, films, disks, rectangular blocks, closed cylinders, cylinders having one or more apertures (or bores) extending therethrough, and the like.
• the structure also may be in the form of a collection of woven or non-woven fibers comprising the antimicrobial polymeric material.
• a device for antimicrobial fluid treatment includes a collection of particles which comprise a miscible blend of one or more antimicrobial bisguanide compounds blended with at least one thermoplastic polymer.
• the antimicrobial bisguanide and thermoplastic polymer may be combined in any amount in which the resulting antimicrobial polymeric material has sufficient antimicrobial activity and retains the structural integrity or porosity needed for a particular use of the antimicrobial polymeric material.
• the antimicrobial bisguanide compound should be present in an amount sufficient to facilitate contact between the antimicrobial polymeric material and the fluid in need of treatment.
• the miscible blend is from about 1% to about 25% by weight antimicrobial bisguanide compound.
• the miscible blend is from about 5% to about 15% by weight antimicrobial bisguanide compound. In still other embodiments, the blend is from about 10% to about 25% by weight. Greater or lesser amounts of antimicrobial bisguanide compound may be selected for use in the antimicrobial polymeric material, depending for example on the required mechanical characteristics (e.g., load bearing characteristics, porosity, etc.) that are specified for the particular fluid treatment application in which the antimicrobial polymeric material is to be used.
• the required mechanical characteristics e.g., load bearing characteristics, porosity, etc.
• the particles have a volume average diameter from about 400 mesh (37 micron) to about 20 mesh (840 micron).
• the particles may have a volume average diameter from about 40 mesh ( ⁇ 420 micron) to about 325 mesh ( ⁇ 44 micron) or from about 80 mesh ( ⁇ 177 micron) to about 200 mesh ( ⁇ 74 micron).
• the particles are porous.
• a pore forming agent known in the art may be incorporated into the fluidized blend prior to solidification.
• the pore forming agent may be a gas or a volatile salt, for example.
• the particles are in a fiber or fibrid form.
• the fluidized blend may be extruded or spun to yield fibers for use in a nonwoven material or woven material.
• the pore size and physical dimensions of the purification material may be manipulated for different fluid treatment applications. Changes in these variables may be selected to accommodate for various flow rates and back-pressure. Similarly, those skilled in the art will recognize that variations in the composition of the purification material will likewise effect the material properties of the purification material.
• the device includes a housing 11 mated with a cap 12, the housing 11 having at least one inlet orifice 13 and at least one outlet orifice 14, wherein the antimicrobial polymeric material 17 is secured in the house in fluid communication between the inlet orifice and the outlet orifice.
• a fluid supply conduit may be joined to the inlet orifice 12, to deliver untreated fluid into the device, and a fluid discharge conduit may be joined to the outlet orifice 14, to conduct treated fluid from the device.
• the fluid may pass into the housing 11 and be forced through the porous purification material 17, which is in the shape of hollow cylinder with an axial bore 18, by the pressure of the fluid flow.
• the antimicrobial polymeric material 17 is in the form of particles in a loose form, e.g., forming a packed bed within the housing.
• the antimicrobial polymeric material 17 is in the form of a porous monolithic structure.
• the porous monolithic structure may be a sintered disk or block.
• the antimicrobial polymeric material 17 is in the form of a nonwoven or woven porous structure (e.g., a filament wrapped filter prepared from spun fibers having the desired tightness and porosity that are wrapped on a suitable core material).
• the antimicrobial bisguanide compound comprises chlorhexidine or a chlorhexidine hydrate.
• chlorhexidine hydrate it should be appreciated that the process of making the antimicrobial polymeric material may result in the loss of the water molecule(s) from the chlorhexidine hydrate, to yield the neat form of chlorhexidine in the antimicrobial polymeric material.
• the antimicrobial bisguanide compound is in an amorphous form in the blend.
• the thermoplastic polymer includes one or more polyolefins. Polyethylene is a preferred thermoplastic polymer in the blend.
• FIGS. 3A-3B show two embodiments where the purification material described herein is in the form of a sheet or film.
• the antimicrobial polymeric material 100 can be used with normal flow-through of a fluid 102 through the antimicrobial polymeric material (FIG. 3A).
• an antimicrobial polymeric material 100 can be used with cross- flow of a fluid 104 across the antimicrobial polymeric material with fluid 102 flowing through the antimicrobial polymeric material (FIG. 3B).
• the cross-flow fluid 104 sweeps across the surface of the antimicrobial polymeric material 100, which may decrease the level of particulate matter deposited thereon.
• the purification material is in the form a porous monolithic structure.
• the structure can be made by compression molding a particulate form of the antimicrobial polymeric material or by extrusion molding the antimicrobial polymeric material.
• the compression molding advantageously and desirably may be molded at ambient temperature conditions, e.g., without input of heat.
• the particulate form of the antimicrobial polymeric material is molded at other non-ambient temperatures. Those skilled in the art will appreciate that such temperatures should be sufficiently below the degradation temperature of the antimicrobial bisguanide in order to avoid impairing its antimicrobial activity.
• the heatless pressure causes the particles to aggregate together, or fuse into a monolithic structure, with no loose particles, while retaining its porosity.
• the purification material may have a melting temperature below its decomposition temperature, allowing it to be molded into different physical shapes without undesirably altering the compound's chemical or structural integrity.
• the present antimicrobial polymeric material is coated on an inert carrier substrate.
• the substrate may be in the form of glass or ceramic beads (e.g., spheres or other shapes) or other loose packing objects which increase the active/available surface area of the antimicrobial polymeric material.
• the present antimicrobial polymeric material is in the form of a woven or nonwoven material.
• Non-woven materials include sheet or web-based structures prepared by bonding together fiber or filaments by chemical, mechanical, heat or solvent treatments known in the art. Such materials may comprise flat, porous sheets made directly from fibers, molten plastic, or plastic film. Those of skill in the art will appreciate that unlike woven materials, nonwoven materials are not made by weaving or knitting, and do not require that the fibers be converted into yarn.
• Woven materials include sheet or web-based structures that are prepared by weaving or knitting fibers or filaments that may be converted into yarn.
• Nonwoven and woven materials comprising the purification material may be engineered to have particular properties, structures, or forms depending upon the desired application using methods known in the art. Methods of preparing such materials are described, for example, in U.S. Patent Nos. 6,548,431; 5,853,883; 5,853,641; and 5,632,944 and U.S. Patent Publication No. 2004/0097158, the disclosures of which are incorporated herein by reference.
• the processing temperature of any process should be sufficiently below the degradation temperature of the antimicrobial polymeric materials such that there is substantially no degradation of the antimicrobial polymeric materials.
• the particles and other devices formed by molecularly distributing the antimicrobial bisguanide compound with the polymer are believed to have surface properties that are antimicrobial due to the presence of antimicrobial bisguanide compound which is immobilized with the polymer chain network.
• the surfaces of these particles should retain their antimicrobial activity until they are fouled, which is a common mode of failure for any surface active solid particle known to those of skill in the art.
• the antimicrobial polymeric material is used in combination with other materials and devices known in the art of fluid treatment.
• the purification material or device may be used in a process in series with a filtration device, for example as a pretreatment to remove larger-scale particulate matter and/or as a post treatment to filter out skeletal remains of inactivated microorganisms.
• the fluid may be treated using methods, materials, and systems known in the art to remove other organic or inorganic matter or solutes. Suitable filter media for pre-filtration are described for example in U.S. Pat. Nos. 6,187,192; 6,180,016; 6,957,743; 6,833,075; and 6,861,002; and in U.S. Patent Applications No. 10/276,274 and No. 10/467,679.
• a method for inactivating microbiological contaminants in a fluid.
• the method may include contacting a fluid in need of treatment with particles that comprise a miscible blend of an antimicrobial bisguanide compound blended with at least one thermoplastic polymer.
• the contacting step may include flowing the fluid through pores in or among a collection, or aggregation, of the particles. 1.
• the antimicrobial bisguanide compound Suitable bisguanide compounds exhibit antimicrobial activity.
• antimicrobial activity refers to the property or capability of a material to inactivate microorganisms.
• microorganisms include bacteria, fungi, and viruses.
• the bisguanide compound exhibits broad spectrum antimicrobial activity.
• broad spectrum antimicrobial activity refers to the property or capability of a material to inactivate numerous different, or substantially all, types of microorganisms including bacteria (and its corresponding spores), fungi, protozoa and viruses.
• An antimicrobial agent that inactivates only a select group of microorganisms e.g., either only gram positive cells or only gram negative cells) does not have broad spectrum antimicrobial activity.
• the antimicrobial bisguanide compound is water insoluble
• water insoluble refers to substantial insolubility in aqueous fluids, particularly aqueous fluids having a pH in the range of about 3 to about 11, such as between about 4 and about 9, and particularly in the range of 6.0 to S.O.
• Substantial insolubility may be indicated by measuring less than 0.01% (weight by volume) of the bisguanide compound using conventional detection methods and tools.
• the antimicrobial bisguanide compound is chlorhexidine.
• the antimicrobial polymeric materials include at least one of the bisguanide hydrates described in U.S. Patent No. 7,427,409 or in co-pending U.S. Patent Application No. 12/016,550, the disclosures of which are incorporated herein by reference. Tautomers of such bisguanide compounds may also be suitable.
• the bisguanide compound includes a bisguanide hydrate having the chemical formula (Formula I):
• R] comprises a straight chained, branched, or cyclic alkyl group which may be further substituted with any moieties such as hydrogen, halogen, hydroxyl, amino, amido, alkylamino, arylamino, alkoxy, aryloxy, nitro, acyl, alkenyl, alkynyl, cyano, sulfo, sulfate, mercapto, imino, sulfonyl, sulfenyl, sulfinyl, sulfamoyl, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, anhydride, oximno, hydrazino, carbamyl, phosphonic acid, phosphonato, or any other viable functional group; wherein R 2 and R 3 , independent of one another, comprise a hydrogen, halogen, hydroxy., amino, amido, alky
• y is a number from 1 to 4
• x is a number from 1 to 100, from 1 to 20, from 1 to 10, or from 1 to 8.
• the composition has a degree of hydration greater than 0 and less than 2y.
• the compound having the chemical Formula I comprises a bisguanide hydrate in which ni and n 2 are 1 having the chemical formula:
• R] comprises a straight chained, branched, or cyclic alkyl group which may be further substituted with any moieties such as hydrogen, halogen, hydroxyl, amino, amido, alkylamino, arylamino, alkoxy, aryloxy, nitro, acyl, alkenyl, alkynyl, cyano, sulfo, sulfato, mercapto, imino, sulfonyl, sulfenyl, sulfinyl, sulfamoyl, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, anhydride, oximno, hydrazino, carbamyl, phosphonic acid, phosphonato, or any other viable functional group; wherein R 2 and R 3 , independent of one another, comprise a hydrogen, halogen, hydroxy., amino, amido, alky
• y is a number from 1 to 4
• x is a number from 1 to 100, from 1 to 20, from 1 to 10, or from 1 to 8.
• the composition has a degree of hydration greater than 0 and less than 2y .
• the functional group desirably does not eliminate or substantially impair the antimicrobial activity or chemical stability of the compound.
• R 1 generally should not be an unsaturated compound because it would prevent the transfer of electrons via double or triple bonds, disturbing the tautomerism on each side of the bisguanide that is responsible for the partial charge of the guanide groups.
• Ri may, however, include an isolated double or triple bond non- conjugated with other carbon atoms and with a single bond carbon atom (or more than one carbon atom) adjacent the guanide groups because the double or triple bond would not have electronic communication with the guanide groups and would not interfere with the tautomerism necessary for stabilization of the partial charges on each of the guanide groups.
• a further example relates to functional groups R 2 and R 3 , which should be electron- withdrawing groups which are capable of assisting in the stabilization of the compound.
• the bisguanide hydrate of Formula I comprises chlorhexidine hydrate, having the chemical formula wherein Ri is methylene, R 2 and R 3 each are a chlorophenyl, ni is 1, n 2 is 1, x is 6, andy is
• the composition has a degree of hydration that is greater than 0 and less than 2.
• R 2 and R 3 independent of one another, are electron-withdrawing groups.
• R 2 and R 3 are independently aryls, are independently substituted aryls, or are independently phenyls. In another embodiment of the bisguanide hydrate of Formula I, R 2 and R 3 are independently substituted phenyls.
• the independently substituted phenyls may have ortho, para, or meta substitutions.
• the independently substituted phenyls may be identical to or different from one another.
• R 2 and R 3 are independently substituted halo phenyls.
• the independently substituted halo phenyls may have ortho, para, or meta substitutions.
• the independently substituted halo phenyls may be identical to or different from one another.
• R 2 and R 3 may independently be substituted halogens, substituted amines, substituted amides, substituted cyanos, or substituted nitros.
• the bisguanide compound includes the "neat" bisguanide composition having the chemical formula (Formula II):
• Ri comprises a straight, chained, branched, or cyclic alkyl group which may be further substituted with any moieties such as hydrogen, halogen, hydroxyl, amino, amido, alkylamino, arylamino, alkoxy, aryloxy, nitro, acyl, alkenyl, alkynyl, cyano, sulfo, sulfato, mercapto, imino, sulfonyl, sulfenyl, sulfinyl, sulfamoyl, phosphonyl, phosphinyl, phosphoiyl, phosphino, thioester, thioether, anhydride, oximno, hydrazino, carbamyl, phosphonic acid, phosphonato, or any other viable functional group; wherein R 2 and R 3 , independent of one another, comprise a hydrogen, halogen, hydroxyl, amino, amido
• Ri comprises a straight, chained, branched, or cyclic alkyl group which may be further substituted with any moieties such as hydrogen, halogen, hydroxyl, amino, amido, alkylamino, arylamino, alkoxy, aryloxy, nitro, acyl, alkenyl, alkynyl, cyano, sulfo, sulfato, mercapto, imino, sulfonyl, sulfenyl, sulfinyl, sulfamoyl, phosphonyl, phosphinyl, phosphoiyl, phosphino, thioester, thioether, anhydride, oximno, hydrazino, carbamyl, phosphonic acid, phosphonato, or any other viable functional group; wherein R 2 and R 3 , independent of one another, comprise a hydrogen, halogen, hydroxy., amino, amido
• the antimicrobial bisguanide compound of Formula III comprises chlorhexidine, a compound having the chemical formula
• Ri is a methylene
• R 2 and R 3 each are a chlorophenyl
• x is 6
• y is 1.
• antimicrobial bisguanide compounds form the heterocyclic ring structure below.
• antimicrobial bisguanide compounds provided herein include their tautomers.
• the thermoplastic polymer The thermoplastic polymer.
• the thermoplastic polymer material of the antimicrobial polymeric material generally is selected taking into consideration its ability to form a molecular mixture. That is, the thermoplastic polymer and antimicrobial bisguanide should have sufficient molecular interactions with each other to permit distribution and immobilization of the antimicrobial bisguanide between the polymer chains.
• the molecular interactions include chemical interactions other than covalent bonds. Examples of such interactions include hydrogen bonding, Van der Waals forces, and other dispersive forces which would be expected between molecularly distributed compositions.
• the antimicrobial bisguanide and the thermoplastic polymer are substantially miscible with one another. In this way, the antimicrobial bisguanide can be distributed at the molecular level throughout the polymer. That is, the antimicrobial polymeric material may include a molecular mixture of these two components.
• substantially soluble or substantially miscible as used herein refers to the ability of the antimicrobial bisguanide to dissolve in a fluidized form of the thermoplastic polymer, such as a polymer melt, or in a solution of the polymer and an organic solvent.
• a miscible blend refers to a molecular mixture of two or more components.
• the melting temperature of the polymer may be an important factor in the selection of a suitable polymer material.
• the melting temperature of the thermoplastic polymer must be such that the antimicrobial bisguanide compound is capable of mixing with the thermoplastic polymer when it is in its liquid state without being so high that the antimicrobial bisguanide degrades to a significant extent before the antimicrobial polymeric material can be cooled.
• the thermoplastic polymer has a melting temperature below about 165°C, more particularly below about 135°C, and still more particularly below about 12O°C.
• Ae thermoplastic polymer may have a higher melting temperature if the polymer can be transformed into a liquid state without heating, e.g., by forming a solution with a suitable solvent, or if the heated polymer melt can be cooled rapidly enough following mixing.
• thermoplastic polymer materials include polyolefins, polyethylenes such as ethylene adipate, ethylene oxide, low density polyethylene, and high density polyethylene, and vinyl polymers such as ethyl vinyl ether, propyl vinyl ether, vinyl acetal, vinyl butyral, and butyl vinyl ether.
• the solubility of two or more components may be determined using empirical models which evaluate the intermolecular forces between the solvent and the solute and the entropy change accompanying the solvation.
• the Hansen Solubility Parameters of each component may be calculated from three-dimensional solubility coefficients which account for the dispersion bonds, polar bonds, and hydrogen bonds between molecules. The three parameters can be treated as coordinates for a point in three dimensions such that the nearer two molecules are in the three dimensional space, the more likely they are to dissolve in each other.
• the Hildebrand Solubility Parameter ( ⁇ ) also provides a means of evaluating the probable solubility of compositions, where materials with similar values of ⁇ provide a good indication of solubility.
• the antimicrobial bisguanide and thermoplastic polymer may be combined in any amounts in which the resulting polymer blend has sufficient antimicrobial activity while not substantially impairing the structural integrity of resulting polymer blend.
• the antimicrobial bisguanide should be present in an amount sufficient to facilitate contact between the antimicrobial bisguanide and the fluid in need of treatment.
• the amount of antimicrobial bisguanide compound can be selected for use in the antimicrobial polymeric material, depending for example on the required mechanical characteristics (e.g., load bearing characteristics, porosity, etc.) that are specified for the particular fluid treatment application in which the antimicrobial polymeric material is to be used.
• the antimicrobial polymeric material optionally may further include one or more additional components.
• the additional component may be a plasticizer.
• the additional component may be in solid solution with the polymer.
• the additional component may be, for example, in particulate or fiber form.
• These other components may, for example, be useful in fluid purification, such as carbon, zeolites, etc. They may be homogeneously or heterogeneously distributed in the antimicrobial polymeric material.
• the additional component is present in the antimicrobial polymeric material in an amount from about 0.1 wt % to about 20 wt. %.
• the antimicrobial bisguanide and thermoplastic polymer may be combined by any suitable means known to those of ordinary skill in the art. Such methods should allow for preparation of a substantially miscible blend in which the antimicrobial bisguanide is substantially undegraded.
• a method for preparing the antimicrobial polymeric materials comprises melting an antimicrobial bisguanide compound and a thermoplastic polymer with which the antimicrobial bisguanide compound is miscible; mixing the melted antimicrobial bisguanide compound and the melted thermoplastic polymer to form a miscible blend of the antimicrobial bisguanide compound dispersed in the thermoplastic polymer; and cooling the miscible blend to solidify the blend.
• thermoplastic polymer and antimicrobial bisguanide compound may be melted using any suitable means known to those skilled in the art as long as the antimicrobial bisguanide compound and thermoplastic polymer remain substantially undegraded. That is, the processing temperature must be sufficiently high to melt the thermoplastic polymer without being so high that the antimicrobial bisguanide compound degrades to a significant extent before the antimicrobial polymeric material can be cooled.
• the thermoplastic polymer is melted by heating the thermoplastic polymer above its melting temperature, and the antimicrobial bisguanide compound may be mixed with the melted thermoplastic polymer to form a miscible blend of the antimicrobial bisguanide compound dispersed in the thermoplastic polymer.
• the thermoplastic polymer and antimicrobial bisguanide compound may be blended before or after melting the thermoplastic polymer and antimicrobial bisguanide compound, as illustrated in Figures 4A and 4B.
• thermoplastic polymer is dissolved in a suitable solvent and blended with the antimicrobial bisguanide compound. Because of the substantial insolubility of the antimicrobial bisguanide compound, however, such methods may still require heating of the antimicrobial bisguanide compound in order to obtain a miscible blend of the antimicrobial bsiguanide compound dispersed in the thermoplastic polymer. Methods for solvent casting of thermoplastic polymers are well known to those skilled in the art.
• the method for preparing an antimicrobial polymeric material comprises the extrusion process illustrated in Figure 5.
• the extrusion process generally comprises feeding the thermoplastic polymer to the extruder and heating the thermoplastic polymer above its melting temperature to obtain a thermoplastic polymer melt, adding an insoluble antimicrobial material to the thermoplastic polymer melt and vigorously mixing to molecularly disperse the antimicrobial material throughout the thermoplastic polymer, and cooling the temperature of the heated blend to obtain a solid antimicrobial polymeric material.
• the mixing of the mixture and speed at which the mixture is passed through the extruder may be controlled by modifying the rate of rotation of the rotating screw in the extruder.
• the hearing profile of the extruder may be controlled using multiple independent controlled heater zones to gradually increase the temperature of the melt and minimize the length of time the mixture is exposed to higher temperatures, thereby minimizing the potential for degradation of the antimicrobial bisguanide compound.
• extruders comprise three or more independently controlled heater zones.
• the porosity and structure of the antimicrobial polymeric material may be modified during the extrusion process. By increasing the porosity of the antimicrobial polymeric material, the surface area of the antimicrobial bisguanide compound that is exposed also may be increased, thereby enhancing the antimicrobial activity of the antimicrobial polymeric material.
• blowing agent e.g., physical or chemical blowing agents, non-limiting examples of which include inert gases such as air and nitrogen
• voids should not substantially impair either the physical integrity of the antimicrobial polymeric material or the overall surface charge of the antimicrobial polymeric material.
• the resulting antimicrobial polymeric material is further processed into particles using methods well known in the art.
• the polymer blend may be pulverized to obtain particle sizes which are suitable for the desired use, using various size reduction equipment known in the art including, but not limited to, mills, grinders, and the like.
• the cooled antimicrobial polymeric material is pulverized to a desired particle size by means of a blender.
• the particles is pulverized to a desired particle size using cryogenic methods.
• the resulting antimicrobial polymeric material is further processed into suitable structures by any suitable means known to those in the art (e.g., molding, die casting, etc.).
• the antimicrobial polymeric material is molded into a suitable monolithic porous structure.
• the antimicrobial polymeric material is formed into fibers (e.g., nonwoven or woven materials).
• the processing temperature of any molding process should be sufficiently below the degradation temperature of the antimicrobial bisguanide compound such that there is substantially no degradation of the antimicrobial bisguanide compound.
• the degradation temperature of the antimicrobial bisguanide compounds may be evaluated by considering the TGA and DSC thermograms of the antimicrobial bisguanide compound. Illustrative TGA thermograms (FIGURE 6A and 6B) and DSC thermograms ( Figure 7A and 7B) of chlorhexidine and chlorhexidine hydrate, respectively, are provided.
• compositions and treatment devices described herein have numerous applications.
• the treatment devices are of a nonsoluble and nonconsumable catalytic nature, and may be capable of inactivating a broad spectrum of microorganisms.
• the compositions and purification materials can be used in applications where it is desirable to reduce and/or eliminate microorganisms in a fluid.
• Nonlimiting examples of such fluids include aqueous solutions, water, air, and other gases.
• the antimicrobial polymeric materials described herein are incorporated into treatment devices for water purification.
• Such treatment devices may be installed at the point of use. This may eliminate the need for chlorination of water supplies to protect against contamination of microorganisms.
• the purification material may be portable for obtaining potable drinking water at any time or place. These devices would be especially desirable in undeveloped countries where one of the greatest needs is potable drinking water.
• the purification material and method are particularly useful in those applications where the required reduction in the concentration of microbiological contaminants significantly exceeds the U.S. EPA standards for microbiological water purification devices.
• the microbiological contaminants are inactivated when a fluid is forced through the purification material by a difference in pressure on the influent and effluent sides or by a vacuum on the effluent side, of the purification material.
• the purification material may be used to purify water used for recreational purposes, such as water used in swimming pools, hot tubs, and spas, allowing the chlorine normally required to eliminate living microorganisms to be either reduced or completely eliminated.
• the present antimicrobial polymeric materials and devices can be used for low-temperature sterilization techniques, eliminating the need for techniques requiring elevated temperatures and pressures, such as pasteurization. This would prove especially useful for both the food and beverage industries.
• the purification material efficiently inactivates microorganisms in aqueous solutions, it also has numerous applications in the pharmaceutical and medical fields.
• the purification material may be used to inactivate microorganisms in certain physiological fluids or in devices, e.g., at-home dialysis machines.
• the antimicrobial polymeric materials and devices can be used in hospital or industrial areas requiring highly purified air having extremely low amounts of microorganisms, e.g., intensive care wards, operating rooms, clean rooms used for care of immunosuppressed patients, or industrial clean rooms for manufacturing electronic and semiconductor equipment.
• the purification materials also can be used for residential air-purification. Such applications would be especially useful for individuals who suffer from heightened reactivity to air-borne microorganisms.
• the purification material can may be used to augment protection for humans or animals against air-borne microorganisms released in a bioterrorist attack.
• the antimicrobial polymeric materials may be incorporated into a device designed to eliminate pathogenic protozoa (e.g., of the genus Plasmodium and phylum Apicomplexa) that cause diseases such as malaria Malaria is typically transmitted to humans through mosquitoes and remains a leading cause of death in undeveloped countries.
• pathogenic protozoa e.g., of the genus Plasmodium and phylum Apicomplexa
• Mosquitoes are infected with the protozoa from water reservoirs and lakes where the mosquitoes breed. Eliminating the protozoa from the breeding habitats of the mosquitoes may help eliminate outbreaks of malaria Numerous other applications exist for which the present antimicrobial polymeric materials and purification materials can be used.
• Representative examples include the treatment of water used in cooling systems, fermentation applications and cell culture, and inactivation of microorganisms in gases (e.g., anesthetics, carbon dioxide used in carbonated beverages, gases used to purge process equipment, etc.).
• gases e.g., anesthetics, carbon dioxide used in carbonated beverages, gases used to purge process equipment, etc.
• the method of using the present antimicrobial polymeric materials and purification materials is relatively simple: The fluid to be treated is brought into physical contact with the antimicrobial polymeric materials. Typically, the fluid will be forced from one side of the porous purification material through to the other side of the purification material due to a pressure drop across the purification material.
• the pressure driven flow can be conducted using conventional fluid pumps or gravity fed.
• the antimicrobial polymeric materials provided herein also may be used for numerous alternative uses (i.e., unrelated to fluid treatment) in which it is desirable to have antimicrobial properties.
• the antimicrobial polymeric materials may be utilized in medical devices to minimize the risk of contamination.
• Non- limiting examples of such devices include bandages for wound treatment on which the antimicrobial polymeric material is coated onto or incorporated into, stents, catheters, or other implantable medical devices (e.g., dental implants, prosthetic joints, etc.).
• the antimicrobial polymeric material may be processed into a woven or non- woven fiber form for forming a flexible porous sheet that can be incorporated into a bandage or gauze.
• the antimicrobial polymeric materials may be utilized as coatings on surfaces or in substantially impermeable monolithic structures in which antimicrobial activity would be desirable.
• Non-limiting examples of such devices include coatings on surfaces such as walls, plumes, and vents.
• Example 1 Preparation of a Polyethylene Blend
• a 150 rtiL beaker was equipped with a mechanical stirrer and placed in an oil bath equipped with a thermostat.
• a specified amount of a low density polyethylene (LDPE) was placed into the beaker and heated to 15O°C with stirring.
• a specified amount of chlorhexidine hydrate was added to the melted polyethylene, heated for an additional 10 minutes with stirring, and then cooled to room temperature.
• the resulting mixture cooled to a hard, white solid that was collected, pulverized in a laboratory blender, and placed in a glass vial covered with argon gas.
• LDPE low density polyethylene
• a 150 mL beaker was equipped with a mechanical stirrer and placed in an oil bath equipped with a thermostat.
• a specified amount of polystyrene (PS) was placed into the beaker and heated to 210°C with stirring. Upon heating, the polystyrene was white with a slight discoloration due to thermal decomposition.
• a specified amount of chlorhexidine hydrate was added to the melted polystyrene, heated for an additional 10 minutes with stirring, and then cooled to room temperature. The resulting mixture cooled to a hard, white solid (with discoloration) that was collected, pulverized in a laboratory blender, and placed in a glass vial covered with argon gas.
• Polyurethanes also were combined with chlorhexidine hydrate using methods similar to those described in Examples 1 and 2. However, these polymers and the antimicrobial bisguanide compound did not form the molecular distribution due to a lack of molecular interaction between the two components. As a result, clumps of the bisguandide compound were formed. Thus, the blended product was not a miscible blend.
• the extruder included six temperature zones, with the zone nearest the hopper having a temperature of approximately 100°C and the remaining five temperature zones having temperatures of about 15O°C.
• the thermoplastic polymer was the same low density polyethylene (LDPE) as set forth in Example 1.
• the chlorhexidine was fed into the extruder in an amount sufficient to provide 5 % by weight of the extruded resin.
• the strand of extrudate was chopped to provide an average diameter of 80 mesh pellets.
• a lower temperature polyolefin elastomer type resin (DOW EngageTM 8411) was used to prepare pellets in a commercial extruder.
• the chlorhexidine hydrate was fed into the extruder described in Example 4 in an amount sufficient to provide 10 % by weight of the extruded pellet.
• the pellets were pulverized cryogenically (liquid nitrogen) to provide an average of 20 mesh particles.
• the SEM micrographs ( Figures SA and 8B) of the resulting resin illustrate the failure of the chlorhexidine to form a solid solution with the resin.
• the polymer blends prepared in Examples 1, 4, and 5 hereinabove were pulverized to obtain from 325 to 20 mesh particle sizes and tested for antimicrobial activity using colonized E. coli dispersions.
• the particles were packed in a 12.0 in x 1.0 in diameter acrylic tube to obtain a particle bed thickness of 0.5 in, 1.0 in, 1.5 in, or 2.0 in.
• a liquid culture of E. coli (10* CFU concentration) was allowed to flow through the packed tube under gravity flow and at STP conditions. Although the flow rate was barely a steady stream, it was sufficient to evaluate the antimicrobial activity of the polymer blends.
• Bacterial recovery was determined by Aerobic Plate Count and is shown in Table 3. The total reduction in bacterial growth was obtained by subtracting the log of the number of colony forming units per mL (CFU/mL) of the effluent samples by the log of the number of CFU/mL of the control.
• FIG. 9A and 9B An SEM micrograph of a dead E. coli cell, shown in Figure 9A and 9B, illustrates the surface-dependent mechanism of the antimicrobial polymer material's antimicrobial activity .
• the sites of collision with the chlorhexidine in the polymer blend are visible and appear to have caused disassembly on the cell wall.
• the cell wall is further magnified in Figure 9B, where the frayed fibrous cell wall material can be observed.
• a typical dead E. coli cell ( Figure 10) does not show any change in its surface morphology except for possible shrinkage due to loss of cytoplasm.
• This mechanism of activity generally is attributed to a soluble oxidant or surface active agent, such as a soluble chlorhexidine salt, that undergoes a second order chemical reaction (i.e., the agent is consumed in a stoichiometric type relationship).
• a soluble oxidant or surface active agent such as a soluble chlorhexidine salt
• the antimicrobial polymer blend conversely, appears to react catalytically with the microorganisms and is not consumed during the reaction.
• the effluent water stream from Example 6 also was tested by a standard HPLC method to evaluate the amount, if any, of the antimicrobial bisguanide that may have leached into the effluent water. Less than 2 ppm of the insoluble antimicrobial bisguanide compound was detected in the effluent of the low density polyethylene alloys produced on the lab scale, while less than 1 ppm of the insoluble antimicrobial bisguanide compound was detected in the effluent of the low density polyethylene alloys produced on the production scale. These extremely low concentrations indicate advantageously that substantially all of the insoluble antimicrobial bisguanide compound remained distributed within the polymer blend.
• soluble antimicrobial bisguanide salts e.g., chlorhexidine gluconate

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Hydrology & Water Resources (AREA)
• Organic Chemistry (AREA)
• Chemical & Material Sciences (AREA)
• Water Supply & Treatment (AREA)
• Environmental & Geological Engineering (AREA)
• General Health & Medical Sciences (AREA)
• Health & Medical Sciences (AREA)
• Pest Control & Pesticides (AREA)
• Zoology (AREA)
• Environmental Sciences (AREA)
• Wood Science & Technology (AREA)
• Dentistry (AREA)
• Plant Pathology (AREA)
• Agronomy & Crop Science (AREA)
• Toxicology (AREA)
• Agricultural Chemicals And Associated Chemicals (AREA)
• Compositions Of Macromolecular Compounds (AREA)

Priority Applications (5)

Applications Claiming Priority (2)

Publications (1)

Family

ID=41611116

Family Applications (1)

Country Status (9)

Families Citing this family (6)

Citations (8)

Family Cites Families (27)

• 2009
  • 2009-11-20 MX MX2011005333A patent/MX2011005333A/es not_active Application Discontinuation
  • 2009-11-20 WO PCT/US2009/065284 patent/WO2010059917A1/en active Application Filing
  • 2009-11-20 BR BRPI0921066A patent/BRPI0921066A2/pt not_active IP Right Cessation
  • 2009-11-20 CN CN200980154401XA patent/CN102272055B/zh not_active Expired - Fee Related
  • 2009-11-20 US US12/622,456 patent/US10322954B2/en active Active
  • 2009-11-20 PE PE2011001065A patent/PE20110680A1/es not_active Application Discontinuation
  • 2009-11-20 EP EP09764391A patent/EP2365942A1/en not_active Withdrawn
  • 2009-11-20 CA CA2744284A patent/CA2744284A1/en not_active Abandoned
• 2011
  • 2011-05-20 CL CL2011001181A patent/CL2011001181A1/es unknown

Patent Citations (8)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events